What happens when you take St. John's wort with red yeast rice?
St. John's wort speeds up the way your body clears the active cholesterol-lowering compound in red yeast rice, called monacolin K. Monacolin K is chemically identical to the prescription statin lovastatin, and like lovastatin it is broken down by a liver and gut enzyme system known as CYP3A4. St. John's wort is a strong inducer of that enzyme system, meaning it prompts your body to make more of the enzyme and process the compound faster.
The practical result is that less monacolin K stays in your bloodstream, so red yeast rice has a weaker cholesterol-lowering effect. Importantly, this is a loss-of-benefit interaction, not a toxicity one. The direction is the opposite of the better-known interactions where a substance blocks CYP3A4 and raises statin levels, so this pairing does not increase the risk of muscle injury.
Why is this important?
People take red yeast rice specifically to help lower cholesterol. If St. John's wort quietly undercuts that effect, you may believe you are managing your cholesterol when you are not. Because the interaction works through enzyme induction rather than an obvious side effect, there are usually no warning symptoms. The only reliable signal is a blood test showing that your cholesterol is drifting back up.
This matters even more with red yeast rice because its monacolin K content is low, variable, and unregulated from product to product. There is already only a modest cholesterol-lowering effect to work with, so blunting it through enzyme induction can erase much of the benefit you were counting on.
What should you do?
Treat this as a combination to review with a professional rather than one to manage on your own with timing.
- Before starting either one: Tell your doctor or pharmacist about both products and ask whether taking them together makes sense for you.
- While taking both: Have your cholesterol monitored with blood tests so you can see whether red yeast rice is still working. Do not assume it is.
- On spacing: Separating the two by several hours does not fix this interaction. Enzyme induction changes how much enzyme your body makes over days to weeks, so it persists regardless of when in the day you take each product.
- The real decision: Discuss whether to continue both, switch one, or choose a different approach to your cholesterol. This is a "which to keep" conversation, not a "when to take" one.
Which specific products are affected?
This interaction applies to any product containing St. John's wort (Hypericum perforatum), whether sold as a standalone mood supplement, a standardized extract, or part of a blended herbal formula. On the other side, it applies to any red yeast rice product, since the concern is its monacolin K content.
The same enzyme-induction concern extends to prescription statins that are cleared by CYP3A4, including lovastatin and simvastatin. Because red yeast rice's monacolin K is the same molecule as lovastatin, red yeast rice behaves like a statin for the purposes of this interaction. Check supplement labels carefully, as St. John's wort and red yeast rice can each appear in multi-ingredient "combination" products.
The science behind it
Three human studies ground both the mechanism and its clinical direction. Sugimoto and colleagues (2001; PMID:11753267) gave St. John's wort alongside two different statins and found that it reduced the active exposure of the CYP3A4-cleared statin simvastatin through increased first-pass metabolism, while having no effect on pravastatin, which is not a CYP3A4 substrate. This isolates enzyme induction as the mechanism.
Eggertsen, Andreasson, and Andren (2007; PMID:17846933) showed the clinical consequence: when a commercial St. John's wort product was added to patients already stable on simvastatin, their LDL and total cholesterol rose significantly, demonstrating a real loss of lipid control. Izzo, Di Carlo, Borrelli, and Ernst (2005; PMID:15676159) reviewed cardiovascular herb-drug interactions and explicitly name lovastatin among the statins whose plasma concentrations fall with St. John's wort, which is directly on-target for red yeast rice because monacolin K is lovastatin.
No study has tested St. John's wort against red yeast rice directly. The evidence is inferred from statin data via monacolin K's chemical identity with lovastatin, which is a strong and consistent basis, though the specific red yeast rice pairing has not been measured.
Frequently Asked Questions
Does St. John's wort make red yeast rice more dangerous?
No. It makes red yeast rice less effective, not more toxic. The interaction lowers the level of the active compound in your blood, so the risk of muscle-related side effects is not increased. The concern is losing the cholesterol benefit.
Can I just take them at different times of day?
No. Spacing does not help here. This is an enzyme-induction interaction that changes how your body processes the compound over days and weeks, so it applies no matter when you take each product.
How would I know if the interaction is affecting me?
You usually cannot feel it. The reliable way to know is a cholesterol blood test showing your numbers creeping back up while you are taking both.
Is this the same as the interaction between St. John's wort and prescription statins?
Yes, in mechanism. Red yeast rice's active compound, monacolin K, is chemically identical to the statin lovastatin, so it is affected the same way as CYP3A4-cleared prescription statins.
If red yeast rice doses are so low, does the interaction even matter?
It matters because the effect being reduced was already modest, and monacolin K content is variable and unregulated between products. Blunting a small effect can leave you with little real cholesterol-lowering benefit.
Should I stop one of them?
That is a decision to make with your doctor or pharmacist, not on your own. They can weigh why you take each product and whether to continue both, switch, or change your approach.
Key takeaways
- St. John's wort induces the CYP3A4 enzyme that clears red yeast rice's active compound, monacolin K, weakening its cholesterol-lowering effect.
- Monacolin K is chemically identical to the statin lovastatin, so red yeast rice is affected like a CYP3A4-cleared statin.
- This is a loss-of-benefit interaction, not a toxicity one; it does not raise muscle-injury risk.
- Spacing the doses apart does not fix enzyme induction; the interaction persists regardless of timing.
- Review the combination with your doctor or pharmacist and have your cholesterol monitored if you take both.